COMPANY NEWS

We’re excited to exhibit safely in person at the Petfood Forum in Kansas City, Missouri on September 23-24, 2021. If you’re attending also, visit us at booth 1137 to meet with our microbiome experts and learn about our range of clinically backed branded ingredients and custom solutions. Discover how you can add functionality to your pet products by leveraging our DE111® Bacillus subtilis probiotic, PreforPro® ...
Read More

Deerland Probiotics & Enzymes has announced the publication of a new study that is the first of its kind to directly investigate the germination of a spore-forming probiotic strain in the human small intestines. The study, entitled Presence and germination of the probiotic Bacillus subtilis DE111® in the human small intestinal tract, has been published in Frontiers in Microbiology. The randomized, crossover, double-blind, placebo-controlled study ...
Read More

With the world reopening, Deerland is thrilled to once again sponsor Gift of Hope, Inc.’s Charity Golf Classic & Auction. This year will mark the eighth annual edition of this fantastic event, which offers an opportunity to give back to a wonderful organization and network with other leaders in the dietary supplement industry and beyond. This opportunity for community building and camaraderie is especially welcome ...
Read More

Deerland Probiotics & Enzymes, a global supplier of science-backed solutions for microbiome health, has announced the expansion of its branded probiotic spore portfolio with the launch of its newest branded ingredient supporting immune health, MuniSpore™, a science-backed strain of the probiotic Bacillus clausii. MuniSpore is the probiotic strain Bacillus clausii CSI08, a soil-based microorganism. The beneficial effects of the probiotic B. clausii have been attributed ...
Read More

Deerland Probiotics & Enzymes, a global supplier of science-backed solutions for microbiome health, is pleased to announce that its probiotic Bacillus subtilis DE111® has attained a list of published health claims in relationship to its inclusion as a food ingredient under the Food Standards Australia New Zealand (FSANZ) Code. Companies seeking to make a general level health claim for a food ingredient in Australia and ...
Read More

Deerland Probiotics & Enzymes has announced the publication of a new clinical study examining the immune support effects of Bacillus subtilis DE111®. The study, “Examining the Gastrointestinal and Immunomodulatory Effects of the Novel Probiotic Bacillus subtilis DE111” published in the International Journal of Molecular Sciences, is an IRB-approved, randomized, double-blind, placebo-controlled study involving 44 healthy adults (aged 20 to 62). Participants consumed either B. subtilis ...
Read More